4.7 Article

Lung Transplantation After Ex Vivo Lung Perfusion Early Outcomes From a US National Registry

期刊

ANNALS OF SURGERY
卷 275, 期 5, 页码 1006-1012

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/SLA.0000000000004233

关键词

EVLP; ex vivo lung perfusion; lung transplantation

类别

资金

  1. NIH [5T32HL069749, 5T32CA093245]
  2. National Institutes of Clinical and Translational Science [TL1TR002555]
  3. Health Resources and Services Administration [234-2005-37011C]

向作者/读者索取更多资源

This study examines early lung transplant outcomes following EVLP using a large national transplant registry. The results show that EVLP recipients have comparable early outcomes to non-EVLP recipients with similar baseline characteristics. Long-term follow-up data is needed to further assess the impact of EVLP on post-lung transplant outcomes.
Objective: The objective of this study was to examine early lung transplant outcomes following EVLP using a large national transplant registry. Summary of Background Data: Lung transplantation in the United States continues to be constrained by a limited supply of donor organs. EVLP has the potential to significantly increase the available pool of donor lung allografts through the reconditioning of marginal organs. Methods: The united network for organ sharing registry was queried for all adults (age >= 18) who underwent first-time lung transplantation between March 2018 (when united network for organ sharing began collecting confirmed donor EVLP status) and June 2019. Transplants were stratified by EVLP use. The primary outcome was short-term survival and secondary outcomes included acute rejection before discharge and need for extracorpo-real membrane oxygenation support post-transplant. Results: A total of 3334 recipients met inclusion criteria including 155 (5%) and 3179 (95%) who did and did not receive allografts that had undergone EVLP, respectively. On unadjusted descriptive analysis, EVLP and non-EVLP cohorts had similar 180-day survival (92% vs 92%, P = 0.9). EVLP use was associated with a similar rate of acute rejection (13% vs 9%, P = 0.08) but increased rate of early extracorporeal membrane oxygenation use (12% vs 7%, P = 0.04). After adjustment, EVLP use was not associated with significantly increased mortality (adjusted hazard ratio 0.99, 95% confidence interval 0.62-1.58) or acute rejection (adjusted odds ratio 0.89, 95% confidence interval 0.40-1.97) compared to non-EVLP use. Conclusions: In the largest national series of EVLP lung transplant recipients, EVLP is associated with early recipient outcomes comparable to that of non-EVLP recipients with similar baseline characteristics. Longer term follow-up data is needed to further assess the impact of EVLP on post-lung transplant outcomes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据